<html>
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <title>ValueSet-botswana-amr-interpretation-expansion-oids</title>
  <link rel="stylesheet" href="fhir.css"/>
</head>
<body>
<div><p class="res-header-id"/><p style="border: black 1px dotted; background-color: #EEEEEE; padding: 8px; margin-bottom: 8px">Expansion performed internally based on <a href="http://terminology.hl7.org/6.4.0/CodeSystem-v3-ObservationInterpretation.html">codesystem ObservationInterpretation v3.0.0 (CodeSystem)</a></p><p>This value set contains 3 concepts</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>System</b></td><td><b>Display (en-US)</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap"><a name="x-http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation-S"> </a>  <a href="http://terminology.hl7.org/6.4.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-S">S</a></td><td>2.16.840.1.113883.5.83</td><td>Susceptible</td><td><div><p>Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2</p>
<p>[Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.]</p>
<p>[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]</p>
</div></td></tr><tr><td style="white-space:nowrap"><a name="x-http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation-I"> </a>  <a href="http://terminology.hl7.org/6.4.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-I">I</a></td><td>2.16.840.1.113883.5.83</td><td>Intermediate</td><td><div><p>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2</p>
<p>[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.]</p>
<p>[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.]</p>
<p>[Note 3: This class also indicates a &quot;buffer zone,&quot; to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.]</p>
<p>[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]</p>
</div></td></tr><tr><td style="white-space:nowrap"><a name="x-http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation-R"> </a>  <a href="http://terminology.hl7.org/6.4.0/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-R">R</a></td><td>2.16.840.1.113883.5.83</td><td>Resistant</td><td><div><p>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2</p>
<p>[Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.]</p>
<p>[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).]</p>
</div></td></tr></table></div></body>
</html>
